期刊文献+

柴胡疏肝汤加减治疗对肝郁气滞型甲状腺功能亢进患者甲状腺上动脉血流动力学及甲状腺功能的影响 被引量:1

Effect of Modified Chaihu Shugan Decoction on Hemodynamics of Superior Thyroid Artery and Thyroid Function in Patients Liver Stagnation and Qi Stagnation with Hyperthyroidism
下载PDF
导出
摘要 目的观察柴胡疏肝汤加减治疗对肝郁气滞型甲状腺功能亢进(HT)患者甲状腺上动脉血流动力学及甲状腺功能的影响.方法选取2020年11月—2021年10月于本院接受治疗的肝郁气滞型HT患者84例为研究对象,依据随机数字表法分为两组,每组42例.对照组口服甲巯咪唑片治疗,观察组在此基础上服用柴胡疏肝汤加减治疗,均连续治疗12周.比较两组的甲状腺上动脉血流动力学、甲状腺功能、临床疗效及不良反应.结果治疗后,观察组的血流舒张末期血流速度、收缩期峰值分别为(0.18±0.08)m/s、(0.35±0.17)m/s,均低于对照组,组间差异有统计学意义(P<0.05).治疗后,观察组的促甲状腺激素水平为(1.79±0.54)μIU/mL,高于对照组,三碘甲状腺原氨酸、四碘甲状腺原氨酸、游离甲状腺素、游离三碘甲状腺原氨酸水平分别为(2.34±0.34)nmol/L、(84.25±12.43)nmol/L、(18.64±6.34)pg/mL、(5.64±3.45)pg/mL,均低于对照组,组间差异有统计学意义(P<0.05).观察组的治疗总有效率为95.24%,高于对照组的80.95%,差异有统计学意义(P<0.05).两组的不良反应发生率比较,差异无统计学意义(P>0.05).结论肝郁气滞型HT患者采用柴胡疏肝汤加减治疗可提高临床疗效,改善甲状腺上动脉血流动力学及甲状腺功能,安全可靠. Objective To observe the effect of modified Chaihu Shugan Decoction on hemodynamics and thyroid function of superior thyroid artery in patients with liver stagnation and Qi stagnation hyperthyroidism(HT).Methods A total of 84 patients with liver stagnation and Qi stagnation HT who received treatment in the hospital from November 2020 to October 2021 were selected as the research subjects.They were divided into two groups according to random number table method,with 42 patients in each group.The control group was treated with methimazole tablets orally,and the observation group was treated with modified Chaihu Shugan Decoction on this basis.Both groups were treated for 12 weeks.The hemodynamics of superior thyroid artery,thyroid function,clinical efficacy and adverse reactions were compared between the two groups.Results After treatment,the end diastolic velocity and systolic peak value in the observation group were(0.18±0.08)m/s and(0.35±0.17)m/s,respectively,lower than those in the control group,and the differences between the groups were statistically significant(P<0.05).After treatment,the thyroid stimulating hormone level in the observation group was(1.79±0.54)μIU/mL,which was higher than that in the control group,the levels of triiodothyronine,tetraiodothyronine,free thyroxine and free triiodothyronine were(2.34±0.34)nmol/L,(84.25±12.43)nmol/L,(18.64±6.34)pg/mL and(5.64±3.45)pg/mL,respectively,lower than those of the control group,the differences between groups were statistically significant(P<0.05).The total effective rate of observation group was 95.24%,higher than 80.95%of control group,the difference was statistically significant(P<0.05).There was no significant difference in incidence of adverse reactions between the two groups(P>0.05).Conclusion Modified Chaihu Shugan Decoction can improve clinical efficacy,blood flow dynamics of superior thyroid artery and thyroid function in HT patients with liver stagnation and Qi stagnation,and it is safe and reliable.
作者 倪静 NI Jing(Department of Endocrinology,Lanling County People's Hospital,Linyi Shandong,277700,China)
出处 《反射疗法与康复医学》 2022年第11期24-27,共4页 Reflexology And Rehabilitation Medicine
关键词 甲状腺功能亢进症 柴胡疏肝汤加减 血流动力学 甲状腺功能 Hyperthyroidism Modified Chaihu Shugan Decoction Hemodynamics Thyroid function
  • 相关文献

参考文献9

二级参考文献83

  • 1刘少杰,施燕红,王桂芬,李响,韩海霞,郭伟.中医从肝论治甲状腺功能亢进的临床疗效[J].辽宁中医杂志,2020(10):93-96. 被引量:7
  • 2赵根炎.张山雷治疗肝病用药经验述评[J].北京中医,1994,13(4):48-50. 被引量:3
  • 3Gharib H, Papini E. Thyroid nodules: clinical importance, assessment, and treatment. Endocrinol Metab Clin North Am, 2007, 36:707-735.
  • 4AACE/AME Task Force Thyroid Nodules. American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nedules. Endocr Pract, 2006,12:63-102.
  • 5Filetti S, Durante C, Torlontano M. Nonsurgical approaches to the management of thyroid nodules. Nat Clin Praet Endoerinol Metab, 2006, 2:384-394.
  • 6Abalovich M, Amino N, Barbour LA, et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab, 2007, 92 :S1-47.
  • 7Cooper DS, Doherty GM, Haugen BR, et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid, 2006, 16: 109-142.
  • 8沈莹,刘建民.甲状腺功能亢进及抗甲状腺药物与肝损害[J].国际内分泌代谢杂志,2007,27(5):317-320. 被引量:15
  • 9连小兰.甲状腺结节.见:白耀,主编.甲状腺病学[M].北京:科学技术文献出版社,2004.335-336.
  • 10中国甲状腺疾病诊治指南——甲状腺功能亢进症[J].中华内科杂志,2007,46(10):876-882. 被引量:846

共引文献427

同被引文献18

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部